The Latest
-
J&J starts head-to-head PFA trial against Boston Scientific device
The study will compare outcomes on J&J’s Varipulse Pro platform and Boston Scientific’s rival Farapulse PFA system.
-
4 studies to know from HRS 2026
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where market share shifts in pulsed field ablation were on analysts’ minds.
-
Profile
With ultrasound on a chip, Butterfly Network aims for global reach
Butterfly, which makes handheld imaging machines, hopes to make the technology accessible to more patients with its pricing and AI features.
-
J&J to acquire Atraverse Medical
The FDA-cleared radiofrequency guidewire will slot into J&J’s fast-growing cardiovascular portfolio.
-
Edwards raises 2026 forecast as TAVR sales surge
The stronger outlook follows mixed results from other major medical device makers in the latest quarter, after both Abbott and Boston Scientific cut their full-year guidance.
-
J&J lands CE mark for surgical stapler that works with Ottava robot
Johnson & Johnson sees surgeons’ familiarity with Ethicon devices as a differentiator as it enters a robot market dominated by Intuitive Surgical.
-
CMS, FDA unveil speedier Medicare coverage pathway for breakthrough devices
The pathway is designed to reduce the delay between FDA authorization and Medicare coverage for certain Class II and Class III breakthrough medical devices.